JPRN-jRCTs031200436
Completed
Phase 2
A prospective multi-center open trial to evaluate the safety and efficacy of favipiravir and camostat mesilate in patients with COVID-19.
Yutaka Tokue0 sites12 target enrollmentMarch 23, 2021
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- Yutaka Tokue
- Enrollment
- 12
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
It was a registration of a small number of cases and did not lead to a statistical examination.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) SARS\-CoV\-2 test positive
- •2\) diagnosed with COVID\-19
- •3\) fever above 37\.5 degree Celsius, or pneumonia shadow on chest X\-ray or CT\-scan
- •4\) hospital admission
- •6\) patients who have given written consent to participate in the study
Exclusion Criteria
- •1\) pregnancy
- •2\) lactation
- •3\) Women who are not able to give informed consent regarding contraception and using contraceptive divices from the initiation of favipiravir to 14 days after the end of its administration. Men or their partners who are not able to give informed consent regarding contraception and using contraceptive divices from the initiation of favipiravir to 10 days after the end of its administration.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Trial of the effectiveness of nutritional intervention for patients who are administered TS-1 after surgical resection of pancreatic cancerpancreatic cancerJPRN-jRCT1051180068Toyama Hirochika35
Not yet recruiting
Phase 2
An Open Label, Multicentre Clinical Study to Assess Oral Safety and Efficacy of Himalaya ToothpasteCTRI/2022/07/043705Himalaya wellness company
Active, not recruiting
Not Applicable
An Open Randomized Multicenter Clinical Investigation to Compare the Efficacy and Safety of Prednisone plus Adacolumn® GMA Apheresis versus Prednisone Alone in the Treatment of Patients with Mild or Moderately Active Steroid Dependent Ulcerative ColitisMild or Moderately Active Steroid Dependent Ulcerative ColitisMedDRA version: 14.0Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2007-003815-30-PTGETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa)
Not yet recruiting
Phase 4
Effect of Chahel tablets in patients having Stress Issues.CTRI/2023/10/058410Ambic Ayurved India Pvt. Ltd.
Completed
Not Applicable
A clinical study to evaluate the effect of a Diaper Rash Cream in Healthy Babies of 6 to 36 Months of Age.CTRI/2024/05/066744prising Science Private Limited36